期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Hepatic venous pressure gradient measurement guiding nonselective beta-blocker therapy in a patient with clinically significant portal hypertension
1
作者 Kun Wang Minghui Tian +3 位作者 Linpeng Zhang Shanghao Liu Xiaoqing Guo Jianzhong Ma 《Portal Hypertension & Cirrhosis》 2023年第2期105-108,共4页
Clinically significant portal hypertension(CSPH),defined as a hepatic venous pressure gradient(HVPG)≥10 mmHg,is an independent risk factor for decompensated events in patients with compensated cirrhosis.Currently,the... Clinically significant portal hypertension(CSPH),defined as a hepatic venous pressure gradient(HVPG)≥10 mmHg,is an independent risk factor for decompensated events in patients with compensated cirrhosis.Currently,the Baveno VII consensus recommends using nonselective beta-blockers to treat compensated cirrhosis in patients with CSPH.Here,we report a unusual case of compensated cirrhosis with CSPH caused by hepatitis B,and we successfully adjust NSBBs drug treatment strategies monitoring by HVPG results and achieve response standards.Timely adjustment of NSBBs drug treatment strategies based on HVPG test results for patients with CSPH can improve the final response rate. 展开更多
关键词 Hepatic venous pressure gradient nonselective beta‐blocker Portal hypertension
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部